ArticleCancer medicine2026
Efficacy and Safety of Multivisceral Resection for Ovarian Cancer: A Comparative Study of Gynecologic Oncologists and Multidisciplinary Surgeons.
Article in Cancer medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundAdvanced ovarian cancer often presents with extensive pelvic and abdominal metastases, even malignant pleural effusion. Consequently, multivisceral resection has become the common surgical approach to achieve optimal resection of ovarian cancer. The present study aimed to evaluate postoperative complications and prognosis of multivisceral resection performed by the independent gynecologic oncologist team (GOT) or multidisciplinary team (MDT).
methodsThe retrospective cohort study enrolled ovarian cancer patients who underwent surgery with multivisceral resection in Jiangsu Cancer Hospital. Patients were divided into two groups depending on the surgical team: the GOT and MDT groups. Patient baseline characteristics, surgical outcomes, postoperative complications, and long-term prognosis were compared between the GOT and MDT groups.
resultsBetween January 2017 and June 2024, 299 ovarian cancer patients were included in this study: 83 in the GOT and 216 in the MDT group. The GOT group had shorter operating times (235 vs. 290 min; p < 0.001) and less blood loss (400 vs. 600 mL; p < 0.001) compared with the MDT group. There were no significant differences in postoperative complications and median progression-free survival (PFS) (not reached (NR) vs. 22.8 months; HR = 0.818, 95% CI 0.507-1.320; p = 0.410) between the GOT and MDT groups. In multivariate analysis, HRD positive status was an indicator of a favorable prognosis (HR = 0.453; 95% CI 0.243-0.844; p = 0.013).
conclusionThe results suggest that ovarian cancer patients who underwent multivisceral resection performed by the independent gynecologic oncologist team are safe and feasible. Our team will continue to follow up to obtain more comprehensive survival data to validate this finding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.